Genetics & Genomics Archive — Page 3 of 16
-
August 6, 2025
Clues offer new hope for treating GI tract disorders
Hirschsprung disease is a congenital disorder that occurs in approximately 1 in 5,000 babies. Caused by a lack of ENS neurons in the muscles of the colon, Hirschsprung disease disrupts gut motility, resulting in bowel obstruction. -
July 28, 2025
Large-scale study uncovers 57 genetic hotspots into stuttering origins
The video is produced by the research team to explain the results of the study. Findings from the largest genetic analysis of stuttering are published in Nature Genetics; they point to 48 genes associated with stuttering and highlight neurological pathways of risk. -
July 15, 2025
Multidisciplinary study develops tools for new ‘genomics of interorgan communication’
The research characterizes the molecular “cargo” of circulating extracellular vesicles in obesity and links the findings to human genetic approaches to identify potential therapeutic targets for metabolic disease. -
July 1, 2025
New lab for transplant, other specialized testing launches at Vanderbilt Medical Laboratories
The new Histocompatibility and Immunogenetics Laboratory launched its first phase of testing June 26 and ultimately will fully support clinical testing for the Vanderbilt Transplant Center, the nation’s third busiest transplant center by volume. -
June 23, 2025
Low blood cell counts drive cancer in explosive blood disorder: study
The analysis of genetic sequencing data from more than 34,000 people over a 17-year period by researchers at VUMC was published in eClinicalMedicine. -
June 12, 2025
Tiny zebrafish aid discovery of rare, fatal genetic disease
The children were born in Turkey with a smaller-than-normal head size, cataracts, severe developmental delay, intellectual disability and epilepsy. -
April 25, 2025
Polygenic score for height could improve diagnosis for children with short stature: study
Even after comprehensive testing, about 30% of children with short stature — height below the third percentile on a growth chart — do not have a definitive diagnosis, leading to extended surveillance, testing and anxiety.